🇺🇸 FDA
Patent

US 11332727

Method for reducing an immune response by administering an immune evading adeno-associated AAV8 or AAVDJ viral vector

granted A61KA61K38/00A61K48/005

Quick answer

US patent 11332727 (Method for reducing an immune response by administering an immune evading adeno-associated AAV8 or AAVDJ viral vector) held by The Regents of the University of California expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61K48/005, A61K49/0008, A61P